在TAVI的三个Cusp视图导向:评估LOA与非LOA对当代门假肢结果的影响
Rim Kasem Ali Sliman1, Amnon Eitan1,2, Keren Zisman1,2
1Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
概括
通过导管的大动脉植入 (TAVI) 的最佳投影视图不会影响设备的成功. 大动脉的负荷和假肢类型是结果的关键决定因素,指导程序规划和监测.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗成像医学成像
背景情况:
- 理想的投射视图对于成功的跨导管大动脉植入 (TAVI) 是至关重要的.
- 了解三角视图定向的影响,特别是对齐线 (LOA),对于完善TAVI程序至关重要.
研究的目的:
- 调查LOA与非LOA投影观点对TAVI患者手术结果的影响.
- 为了确定设备成功的预测因素,手术后的血液动力学和TAVI中的心脏起器植入.
主要方法:
- 对421名用SAPIEN 3或CoreValve Evolut R/PRO假肢进行移植TAVI的患者进行了回顾性分析.
- 根据手术前的CT扫描,将患者分为LOA (n=312) 或非LOA (n=109) 的分类.
- 评估主要终点,包括设备成功 (VARC-2),大动脉吐和30天的结果;使用多变量逻辑回归.
主要成果:
- 非LOA患者表现出更大的圆环尺寸和更高的负荷,需要更多的对比度.
- 大动脉的分数是设备成功的唯一独立预测指标;LOA方向显示没有显著的关联.
- 门类型确定了手术后的血液动力学 (SAPIEN 3高级),以及先前捆绑分支块预测的起器需求.
结论:
- 在TAVI中,LOA方向影响了解剖学特征,但并没有影响基本的治疗决策.
- 负担和门类型仍然是TAVI结果的主要决定因素.
- 在不改变核心处理策略的情况下,LOA状态应指导程序规划,对比度管理和监控.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Mitral Regurgitation III: Medical Management
30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Mitral Valve Prolapse III: Nursing Management
36
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
36
Mitral Valve Prolapse I: Introduction
42
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
42
Aortic Regurgitation III: Medical Management
42
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
42


